Literature DB >> 7995292

Assessment of tumour necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with technetium-99m sestamibi imaging: comparison with CT scan.

C Aktolun1, H Bayhan, Y Pabuccu, H Bilgic, H Acar, R Koylu.   

Abstract

Thirty-eight patients with four major types of bronchial carcinoma were studied to evaluate technetium-99m sestamibi imaging in the assessment of tumour necrosis and the detection of hilar and mediastinal lymph node metastasis. Quantitative analysis was also performed to ascertain whether tumour uptake values correlate with histological types of bronchial carcinoma. Of the patients, 34 showed tumour uptake on planar imaging (n = 38) and 27 on single-photon emission tomography (SPET) (n = 29), the overall sensitivity in the localisation of primary tumour being 89% with planar imaging and 93% with SPET. Four types of tumour uptake pattern were identified: (1) focal uptake, (2) focal uptake with a central hypoactive focus. (3) ring-like uptake and (4) no uptake (negative uptake). Tumour necrosis was diagnosed in 12 patients based upon histopathology (n = 2) and density measurements and type of contrast enhancement on computed tomography (CT) scan (n = 12). Defective tumour uptake was seen in 11 of these patients on planar images (focal uptake with a central hypoactive focus, n = 7; ring-like uptake, n = 2; and no tumour uptake, n = 2) and in 12 patients on SPET (focal uptake with a central hypoactive focus, n = 7, ring-like uptake, n = 3, and no uptake, n = 2). Hilar and mediastinal lymph node involvement was detected in ten patients on CT scan, nine on planar images and 11 on SPET. A total of 26 metastatic lymph nodes were detected on CT scan: 24 of these were seen on planar, and all 26 on SPET images.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995292     DOI: 10.1007/BF00238122

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  20 in total

1.  Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability?

Authors:  R S Beanlands; F Dawood; W H Wen; P R McLaughlin; J Butany; G D'Amati; P P Liu
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

2.  201Tl as a tumour-localizing agent.

Authors:  C Aktolun
Journal:  Nucl Med Commun       Date:  1993-11       Impact factor: 1.690

3.  Study of the distribution of tumor affinity metal compounds and alkaline metal compounds in the tumor tissues by macroautoradiography.

Authors:  A Ando; I Ando; S Sanada; M Katayama; T Hiraki; K Doishita; M Midzukami; K Hisada
Journal:  Int J Nucl Med Biol       Date:  1984

Review 4.  The applications of PET in clinical oncology.

Authors:  L G Strauss; P S Conti
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

5.  Evaluation of primary lung carcinoma using technetium 99m-hexamethylpropylene amine oxime: preliminary clinical experience.

Authors:  M Oshima; K Itoh; S Okae; M Tadokoro; Y Kodama; S Sakuma
Journal:  Eur J Nucl Med       Date:  1990

6.  Extrathoracic staging of bronchogenic carcinoma.

Authors:  A Salvatierra; C Baamonde; J M Llamas; F Cruz; J Lopez-Pujol
Journal:  Chest       Date:  1990-05       Impact factor: 9.410

7.  Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

Authors:  E F Patz; V J Lowe; J M Hoffman; S S Paine; P Burrowes; R E Coleman; P C Goodman
Journal:  Radiology       Date:  1993-08       Impact factor: 11.105

8.  In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy.

Authors:  K Higashi; A C Clavo; R L Wahl
Journal:  J Nucl Med       Date:  1993-05       Impact factor: 10.057

9.  Tumor and liver uptake models of 67Ga-citrate.

Authors:  A Ando; I Ando; S Sanada; T Hiraki; K Hisada
Journal:  Eur J Nucl Med       Date:  1985

10.  Increased accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in osteosarcoma and its metastatic lymph nodes.

Authors:  B Caner; M Kitapçi; T Aras; G Erbengi; O Uğur; C Bekdik
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

View more
  5 in total

1.  Ring appearance of Tc-99m MIBI thoracic SPECTs and increased uptake on Tc-99m HMDP thoracic SPECTs in a pulmonary mass of small cell carcinoma.

Authors:  W J Shih; F Turturro; V Stipp; P DeSimone
Journal:  Ann Nucl Med       Date:  1996-11       Impact factor: 2.668

2.  Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.

Authors:  Sheng-Pin Changlai; Chang-Shu Tsai; Hueisch-Jy Ding; Wen-Tao Huang; Albert Kao; Wu-Huei Hsu
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

3.  Technetium-99m-tetrofosmin uptake in malignant lung tumours.

Authors:  T Başoğlu; M Sahin; C Coşkun; A Koparan; I Bernay; L Erkan
Journal:  Eur J Nucl Med       Date:  1995-07

4.  Noncardiac findings on dual-isotope myocardial perfusion SPECT.

Authors:  Kim A Williams; Kalisha A Hill; Candace M Sheridan
Journal:  J Nucl Cardiol       Date:  2003 Jul-Aug       Impact factor: 5.952

5.  99mTc-sesta-(2-methoxy-isobutyl-isonitrile) uptake by pancreatic islets, parotid cells, and mammary carcinoma cells.

Authors:  D Blocklet; H Jijakli; A Sener; A Schoutens; W J Malaisse
Journal:  Endocrine       Date:  1998-08       Impact factor: 3.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.